Lipid metabolism and disorders
Lipid metabolism and disorders is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 20k research works in it since 1950. 17.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the genetic, pharmacologic, and physiological aspects of lipid metabolism, particularly the role of ANGPTL3, lipoprotein lipase, and related proteins in regulating triglyceride levels and their implications for cardiovascular diseases such as familial chylomicronemia syndrome and atherosclerosis. It also explores the involvement of adipose tissue and metabolic syndrome in lipid regulation.
- ANGPTL3
- Lipoprotein Lipase
- Triglyceride Metabolism
- Familial Chylomicronemia Syndrome
- GPIHBP1
- ANGPTL4
- Adipose Tissue
- Metabolic Syndrome
- HDL Cholesterol
- Atherosclerosis
- Research works
- 20k fractional, since 1950
- In the world top 10%
- 3.4k per year above
- Top-10% rate
- 17.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -4% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Lipid metabolism and disorders research?
By volume, China and the United States publish the most (1k and 463 works in 2022–2025).
By volume, 2022–2025
- 1 China 1k works
- 2 United States 463 works
- 3 India 115 works
- 4 Japan 92 works
- 5 Italy 82 works
- 6 Canada 67 works
- 7 United Kingdom 63 works
- 8 Türkiye 58 works
- 9 Russia 58 works
- 10 Germany 56 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Lipid metabolism and disorders research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Lipid metabolism and disorders research, followed by Nanjing Medical University and Shanghai University of Traditional Chinese Medicine.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 23 works
- 2 Nanjing Medical UniversityChina 11 works
- 3 Shanghai University of Traditional Chinese MedicineChina 11 works
- 4 Western UniversityCanada 10 works
- 5 Central South UniversityChina 10 works
- 6 Chengdu University of Traditional Chinese MedicineChina 10 works
- 7 Zhejiang Chinese Medical UniversityChina 10 works
- 8 Shanghai Jiao Tong UniversityChina 10 works
- 9 Capital Medical UniversityChina 9 works
- 10 Peking UniversityChina 9 works
Who are the leading researchers in Lipid metabolism and disorders?
The most-cited researchers publishing on Lipid metabolism and disorders include Winfried März and Aarno Palotie.
- 1 Winfried März Germany 5.2k citations
- 2 Aarno Palotie Finland 4.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Lipid metabolism and disorders research done?
The largest centres of Lipid metabolism and disorders research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).
Where is the best place to study Lipid metabolism and disorders?
Among universities, judged by research, Western University, Chinese Academy of Medical Sciences & Peking Union Medical College and Chengdu University of Traditional Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Western UniversityCanada | 75.2 | 48.2% | 6.9× | 10 | +99.7% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 59.8 | 25.0% | 8.8× | 23 | -41.4% |
| 3 | Chengdu University of Traditional Chinese MedicineChina | 53.2 | 38.3% | 16.7× | 10 | -69.4% |
| 4 | Shanghai University of Traditional Chinese MedicineChina | 47.8 | 27.2% | 21.0× | 11 | -60.2% |
| 5 | Nanjing Medical UniversityChina | 47.5 | 25.2% | 8.3× | 11 | -6.2% |
| 6 | Zhejiang Chinese Medical UniversityChina | 38.7 | 18.0% | 14.4× | 10 | -71.7% |
| 7 | Shanghai Jiao Tong UniversityChina | 38.3 | 37.1% | 1.6× | 10 | +27.3% |
| 8 | Nanjing University of Chinese MedicineChina | 37.8 | 20.2% | 12.7× | 9 | -63.1% |
| 9 | Beijing University of Chinese MedicineChina | 35.3 | 16.8% | 17.8× | 8 | -48.0% |
| 10 | Huazhong University of Science and TechnologyChina | 30.9 | 35.9% | 2.0× | 8 | -9.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Lipid metabolism and disorders research growing?
Output in 2018–2022 was 4% lower than in 2013–2017, peaking in 2013. The fastest-growing topics are Lipid metabolism and disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.